Correlation Between Medy Tox and INtRON Biotechnology
Can any of the company-specific risk be diversified away by investing in both Medy Tox and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medy Tox and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medy Tox and iNtRON Biotechnology, you can compare the effects of market volatilities on Medy Tox and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medy Tox with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medy Tox and INtRON Biotechnology.
Diversification Opportunities for Medy Tox and INtRON Biotechnology
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Medy and INtRON is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Medy Tox and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and Medy Tox is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medy Tox are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of Medy Tox i.e., Medy Tox and INtRON Biotechnology go up and down completely randomly.
Pair Corralation between Medy Tox and INtRON Biotechnology
Assuming the 90 days trading horizon Medy Tox is expected to under-perform the INtRON Biotechnology. In addition to that, Medy Tox is 1.95 times more volatile than iNtRON Biotechnology. It trades about -0.3 of its total potential returns per unit of risk. iNtRON Biotechnology is currently generating about -0.09 per unit of volatility. If you would invest 587,000 in iNtRON Biotechnology on August 25, 2024 and sell it today you would lose (26,000) from holding iNtRON Biotechnology or give up 4.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Medy Tox vs. iNtRON Biotechnology
Performance |
| Timeline |
| Medy Tox |
| iNtRON Biotechnology |
Medy Tox and INtRON Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medy Tox and INtRON Biotechnology
The main advantage of trading using opposite Medy Tox and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medy Tox position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.The idea behind Medy Tox and iNtRON Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| INtRON Biotechnology vs. Medy Tox | INtRON Biotechnology vs. Oscotec | INtRON Biotechnology vs. Genexine | INtRON Biotechnology vs. Helixmith Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |